Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma

Clinical Cancer Research

Volumn 3, Issue 6, 1997, Pages 977-981

  Gao, Luzhang ^a   Liu, Ling ^a   Van Meyel, Donald ^b   Cairncross, Gregory ^b   Forsyth, Peter ^c   Kimmel, David ^d   Jenkins, Robert B ^d   Lassam, Norman J ^e   Hogg, David ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c TOM BAKER CANCER CENTRE   (Canada)

^d MAYO CLINIC   (United States)

^e DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN KINASE INHIBITOR;

ARTICLE; FAMILIAL CANCER; GENE MUTATION; GLIOMA; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CLUSTER ANALYSIS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA PRIMERS; EXONS; FAMILY; FEMALE; GENE AMPLIFICATION; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; GLIOMA; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0031005559     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
2. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
3. ink4b is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
4. Serrano, M., Lee, H-W., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
5. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 55: 4833-4836, 1995.
6. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
7. 16INK4a binding domain of CDK4 in familial melanoma. Nat. Genet., 12: 97-99, 1996.
8. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
9. INK4A) somatic and germ-line mutations. Hum. Mutat., 7: 294-303, 1996.
10. Cannon-Albright, L. A., Goldgar, D. E., Neuhausen, S., Gruis, N. A., Anderson, D. E., Lewis, C. M., Jost, M., Tran, T. D., Nyguen, K., Kamb, A., Weaver-Feldhaus, J., Meyer, L. J., Zone, J. J., and Skolnick, M. H. Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics, 23: 265-268, 1994.
11. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J. F., Anderson, D. E., Bergman, W., Frants, R., Goldgar, D. E., Green, A., MacLennan, R., Martin, N. G., Meyer, L. J., Youl, P., Zone, J. J., Skolnick, M. H., and Cannon-Albright, L. A. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet., 8: 22-26, 1994.
12. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germ-line p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
13. INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene, 11: 405-412, 1995.
14. Moulton, T., Samara, G., Chung, W. Y., Yuan, L., Desai, R., Sisti, M., Bruce, J., and Tycko, B. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforms. Am. J. Pathol., 146: 613-619, 1995.
15. Spruck, C. H. R., Gonzalez-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M. F., Gonzales, F., Tsai, Y. C., and Jones, P. A. p16 gene in uncultured tumours. Nature (Lond.), 370: 183-184, 1994.
16. Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., and Louis, D. N. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56: 150-153, 1996.
17. Watling, C. J., van Meyel, D. J., Ramsay, D. A., MacDonald, D. R., and Cairncross, J. G. Loss of heterozygosity analysis of chromosomes 9, 10, and 17 in gliomas in families. Can. J. Neurol. Sci., 22: 17-21, 1995.
18. Kaufmann, D. K., Kimmel, D. W., Parisi, J. E., and Michels, V. V. A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma. Neurology, 43: 1728-1731, 1993.
19. Peng, H. Q., Hogg, D., Malkin, D., Bailey, D., Gallie, B. L., Bulbul, M., Jewett, M., Buchanan, J., and Goss, P. E. Mutations of the p53 gene do not occur in testis cancer. Cancer Res., 53: 3574-3578, 1993.
20. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H., Parry, D., Peters, G., and Kamb, A. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res., 55: 2988-2994, 1995.
21. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83: 993-1000, 1995.
22. INK4 function. Nat. Genet., 10: 114-116, 1995.
23. Cannon-Albright, L. A., Thomas, A., Goldgar, D. E., Gholami, K., Rowe, K., Jacobsen, M., McWhorter, W. P., and Skolnick, M. H. Familiality of cancer in Utah. Cancer Res., 54: 2378-2385, 1994.
24. Watkins, D., and Rouleau, G. A. Genetics, prognosis, and therapy of central nervous system tumors. Cancer Detect. Prev., 18: 139-144, 1994.
25. van Meyel, D. J., Ramsay, D. A., Chambers, A. F., Macdonald, D. R., and Cairncross, J. G. Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma. Ann. Neurol., 35: 120-122, 1994.
26. Malkin, D. Germ-line p53 mutations and heritable cancer. Annu. Rev. Genet., 28: 443-465, 1994.
27. Hamilton, S. R., Liu, B., Parsons, R. E., Papadopoulos, N., Jen, J., Powell, S. M., Krush, A. J., Berk, T., Cohen, Z., Tetu, B., Burger, P. C., Wood, P. A., Taqi, F., Booker, S. V., Petersen, G. M., Offerhaus, G. J. A., Tersmette, A. C., Giardiello, F. M., Vogelstein, B., and Kinzler, K. W. The molecular basis of Turcot's syndrome. N. Engl. J. Med., 332: 839-847, 1995.
28. Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., Brownstein, B. H., and Collins, F. S. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (Washington DC), 249: 181-186, 1990.
29. Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., Pulst, S. M., Lenoir, G., Bijlsma, E., Fashold, R., Dumanski, J., de Jong, P., Parry, D., Eldrige, R., Aurias, A., Delattre, O., and Thomas, G. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature (Lond.), 363: 515-521, 1993.
30. INK4 expression is frequent in high grade gliomas. Cancer Res., 55: 1941-1945, 1995.
31. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
32. Fueyo, J., Gomez-Manzano, C., Yung, W. K., Clayman, G. L., Liu, T. J., Bruner, J., Levin, V. A., and Kyritsis, A. P. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene, 12: 103-110, 1996.
33. Tenan, M., Benedetti, S., and Finocchiaro, G. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas. Biochem. Biophys. Res. Commun., 217: 195-202, 1995.
34. Petty, E. M., Gibson, L. H., Fountain, J. W., Bolognia, J. L., Yang-Feng, T. L., Housman, D. E., and Bale, A. E. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor suppressor gene(s). Am. J. Hum. Genet., 53: 96-104, 1993.